A report outlining a plan for assessing opioid pain drugs is due within one year
What the document says“Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall publish on the website of the Food and Drug Administration (referred to in this section as the ``FDA'') a report that outlines a plan for assessing opioid analgesic drugs”
The section directs the Secretary to publish, within one year of enactment, a report on the FDA website outlining a plan for assessing approved opioid analgesic drugs. The plan must address the public health effects of those drugs as part of the benefit and risk assessment, and the agency's work on developing nonaddictive products to treat pain or addiction.
What the document actually says“Not later than one year after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the ``Secretary'') shall publish on the website of the Food and Drug Administration (referred to in this section as the ``FDA'') a report that outlines a plan for assessing opioid analgesic drugs”
The Secretary must put out a report within one year. It goes on the drug agency website. It lays out a plan for checking opioid pain drugs.
An opioid analgesic is a strong pain pill. The plan must weigh good against harm. It must also cover pain drugs that do not hook people.
No action is recorded against this proposal. That is not evidence that none has been taken, and nobody has yet read it against the record. See what the tracker does not yet cover.